Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

SPECTRUM PHARMA (SPPI) IS A BUY

|Includes: Spectrum Pharmaceuticals, Inc. (SPPI)

SPPI has been chopped down this morning to $6.12 and near its 50-day MA of $6.1164.

This is confirmation that that the 50-day MA retest is occuring.  In the past, the 50-day MA retest has proven to be a good place to add to existing long positions in SPPI.

SPPI has several positive catalysts coming up in the weeks and months ahead.


Disclosure: Long SPPI.